PAKIANATHAN DEEPIKA

CIK 000127073413 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001270734

Recent Transactions

50 trades

Award
Karyopharm Therapeutics Inc.$KPTI
Nonstatutory Stock Option (right to buy)
2025-05-28+4,600→ 4,600 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2025-05-19+10,649→ 58,065 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2025-05-19+24,258→ 24,258 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2025-02-05+55,000→ 55,000 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
Share Options (right to buy)
2024-08-22−15,000→ 30,000 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-08-22$1.31/sh+38,953→ 59,688 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-08-22$0.94/sh+43,485→ 103,173 total
Sale
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-08-22$4.43/sh−105,244→ 0 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
Share Options (right to buy)
2024-08-22−31,500→ 0 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
Share Options (right to buy)
2024-08-22−11,000→ 0 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-08-22$3.00/sh+1,825→ 1,825 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-08-22$3.87/sh+2,071→ 105,244 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
Share Options (right to buy)
2024-08-22−55,000→ 0 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
Share Options (right to buy)
2024-08-22−55,000→ 0 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-08-22$1.84/sh+6,492→ 8,317 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-08-22$2.72/sh+12,418→ 20,735 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
Share Options (right to buy)
2024-08-22−5,500→ 0 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-06-07$0.95/sh−2,240→ 0 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-06-07$0.95/sh−229,308→ 0 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-06-06$0.98/sh−117,307→ 229,308 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-06-06$0.98/sh−1,145→ 2,240 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-06-05$0.96/sh−4,526→ 3,385 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-06-05$0.96/sh−463,518→ 346,615 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-06-04$0.95/sh−3,298→ 7,911 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-06-04$0.95/sh−337,742→ 810,133 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-06-03$1.00/sh−3,488→ 11,209 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-06-03$1.00/sh−357,256→ 1,147,875 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-05-31$0.95/sh−202,418→ 1,505,131 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2024-05-31$0.95/sh−1,976→ 14,697 total
Award
Karyopharm Therapeutics Inc.$KPTI
Nonstatutory Stock Option (right to buy)
2024-05-29+69,000→ 69,000 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2024-05-08+10,537→ 47,416 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2024-05-08+23,576→ 23,576 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2024-02-08+45,000→ 45,000 total
Award
Karyopharm Therapeutics Inc.$KPTI
Nonstatutory Stock Option (right to buy)
2023-05-24+34,000→ 34,000 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2023-05-02+22,044→ 22,044 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2023-05-02+9,132→ 36,879 total
Sale
Calithera Biosciences, Inc.
Common Stock
2023-01-27$0.39/sh−120,161→ 0 total
Sale
Calithera Biosciences, Inc.
Common Stock
2023-01-27$0.39/sh−1,172→ 0 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2022-06-10$6.00/sh−13→ 16,673 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2022-06-10$6.00/sh−1,294→ 1,707,549 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2022-06-09$6.18/sh−2,045→ 16,686 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2022-06-09$6.18/sh−209,455→ 1,708,843 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2022-06-08$6.50/sh−3,152→ 18,731 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2022-06-08$6.50/sh−322,825→ 1,918,298 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2022-06-01+20,000→ 20,000 total
Award
Karyopharm Therapeutics Inc.$KPTI
Nonstatutory Stock Option (right to buy)
2022-05-19+23,900→ 23,900 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2022-04-26+28,000→ 28,000 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2022-04-26+9,852→ 27,747 total
Conversion
PARDES BIOSCIENCES, INC.
Class A Common Stock
2021-12-23+52,500→ 52,500 total
Conversion
PARDES BIOSCIENCES, INC.
Class B Common Stock
2021-12-23−52,500→ 0 total

Companies

Recent Filings

Address

C/O DELPHI VENTURES 3000 SAND HILL ROAD, #1-135

MENLO PARK, CA, 94025

View on SEC.gov